Compare ALB & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALB | BIRK |
|---|---|---|
| Founded | 1994 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 5.6B |
| IPO Year | 1995 | 2023 |
| Metric | ALB | BIRK |
|---|---|---|
| Price | $105.03 | $32.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 23 |
| Target Price | ★ $171.56 | $50.74 |
| AVG Volume (30 Days) | ★ 2.3M | 1.9M |
| Earning Date | 11-04-2026 | 08-13-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | ★ 48.57 | N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | ★ $5,142,733,000.00 | N/A |
| Revenue This Year | $19.06 | $11.98 |
| Revenue Next Year | $2.92 | $13.78 |
| P/E Ratio | $18.23 | ★ $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $85.85 | $29.93 |
| 52 Week High | $221.00 | $50.73 |
| Indicator | ALB | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 31.96 | 46.25 |
| Support Level | N/A | $31.33 |
| Resistance Level | $117.59 | $37.29 |
| Average True Range (ATR) | 3.38 | 0.95 |
| MACD | -0.83 | 0.45 |
| Stochastic Oscillator | 0.62 | 67.01 |
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.